Written by admin on November 6th, 2007
ORLANDO, Florida (Reuters) - A European study released on Tuesday has raised new concerns about the safety of women’s long-term use of the birth control pill, suggesting increased risk of heart attack or stroke.
Women who had used oral contraceptives were more likely than those who did not take the pill to have a buildup of […]
Written by admin on November 6th, 2007
The FDA announced that, at the agency’s request, Bayer Pharmaceuticals Corp. has agreed to a marketing suspension of Trasylol (aprotinin injection), a drug used to control bleeding during heart surgery, pending detailed review of preliminary results from a Canadian study that suggested an increased risk for death. FDA requested the suspension in the interest of […]
Written by admin on October 24th, 2007
After a review of postmarketing adverse event reports, FDA determined that an updated label with a boxed warning on the risks of heart failure and other Avandia Side Effects were needed for the entire thiazolidinedione class of antidiabetic drugs.
These drugs are used in conjunction with diet and exercise to improve blood sugar control in adults […]